Biotechnologia Acta

...

  • Increase font size
  • Default font size
  • Decrease font size
Home Archive 2015 № 4 EFFECTS OF C60 FULLERENE — CISPLATIN COMPLEX ON HONEYBEE Apis mellifera L. Kuznietsova H. M., Ogloblya O. V., Cherepanov V. V., Prylutskyy Yu. I., Rybalchenko V. K.

ISSN 2410-7751 (Print)
ISSN 2410-776X (Online)

Biotechnologia Acta
V. 8, N 4, 2015


"Biotechnologia Acta" V. 8, No 4, 2015
https://doi.org/10.15407/biotech8.04.108
Р. 108-112, Bibliography 33, English
Universal Decimal Classification: [546.264+615.277.3]:595.799

EFFECTS OF C60 FULLERENE — CISPLATIN COMPLEX ON
HONEYBEE Apis mellifera L.

Kuznietsova H. M.1, Ogloblya O. V.1, Cherepanov V. V.2, Prylutskyy Yu. I.1, Rybalchenko V. K.1

1Taras Shevchenko National University of Kyiv, Ukraine
2Institute of Physics of the National Academy of Sciences of Ukraine, Kiyv

The toxicity of С60 fullerene, traditional cytostatic cisplatin and С60 fullerene-cisplatin complex on honeybee Apis mellifera L. toxicity estimation test system was assessed. Water-soluble pristine C60 fullerenes were nontoxic for honeybee when consumed with the food in doses equivalent nontoxic and effective ones for mammalian. Cisplatin toxicity for honeybee in the doses exceed the same for mammalian in 2 times was observed as fallows: honeybee 56% death occurred after consumption of 60 mg/kg of bee weight. С60 fullerene-cisplatin complex proved to be more toxic for honeybee in comparison with free cisplatin and caused honeybee 50% lethality after consumption of 40 mg/kg bee weight.

Key words: C60 fullerene, cisplatin, honeybee.

© Palladin Institute of Biochemistry of the National Academy of Sciences of Ukraine, 2008

  • References
    • 1. Bedrov D., Smith G. D., Davande H., Li L. Passive transport of C60 fullerenes through a lipid membrane: a molecular dynamics simulation study. J. Phys. Chem. B. 2008, V. 112, P. 2078–2084.
      http://dx.doi.org/10.1021/jp075149c

      2. Schuetze C., Ritter U., Scharff P., Bychko A., Prylutska S., Rybalchenko V., Prylutskyy Yu. Interaction of N-fluorescein-5-isothiocyanate yrrolidine-C60 compound with a model bimolecular lipid membrane. Mater. Sci. Engineer. C. 2011, 31(5), 1148–1150.
      http://dx.doi.org/10.1016/j.msec.2011.02.026

      3. Foley S., Crowley C., Smaihi M., Bonfils C., Erlanger B. F., Seta P., Larroque C. Cellular localisation of a water_soluble fullerene derivative. Biochem. Biophys. Res. Commun. 2002, V. 294, P. 116–119.
      http://dx.doi.org/10.1016/S0006-291X(02)00445-X

      4. Prylutska S., Bilyy R., Overchuk M., Bychko A., Andreichenko K., Stoika R., Rybalchenko V., Prylutskyy Yu., Tsierkezos N. G., Ritter U. Water-soluble pristine fullerenes C60 increase the specific conductivity and capacity of lipid model membrane and form the channels in cellular plasma membrane. J. Biomed. Nanotechnol. 2012, 8(3), 522–527.
      http://dx.doi.org/10.1166/jbn.2012.1404

      5. Liu J. H., Cao L., Luo P. G., Yang S. T., Lu F., Wang H., Meziani M. J., Haque S. A., Liu Y., Lacher S., Sun Y. P. Fullerene-conjugated doxorubicin in cells. ACS Appl. Mater. Interfaces. 2010, V. 2, P. 1384–1389. http://dx.doi.org/10.1021/am100037y

      6. Prylutska S. V., Korolovych V. F., Prylutskyy Yu. I., Evstigneev M. P., Ritter U., Scharff P. Tumor-inhibitory effect of C60 fullerene complex with doxorubicin. Nanomed. Nanobiol. 2014, , 1(2), 1–5.

      7. Prylutska S. V. Using of C60 fullerene complexes with antitumor drugs in chemotherapy. Biotechnol. acta. 2014, 7(3), 9–20. (Іn Ukrainian). doi: 10.15407/biotech7.03.009.

      8. Panchuk R. R., Prylutska S. V., Chumak V. V., Skorokhyd N. R., Lehka L. V., Evstigneev M. P., Prylutskyy Yu. I., Berger W., Heffeter P., Scharff P., Ritter U., Stoika R. S. Application of С60 fullerene-doxorubicin complex for tumor cell treatment in vitro and in vivo. J. Biomed. Nanotechnol. 2015, 11(7), 1139–1152.

      9. Prylutskyy Yu. I., Zabolotnyy M. A., Solyanyk G. I., Kirkilevska L. M. Immobilization of antitumor drugs on nanoparticles. Biotechnol. acta. 2015,8(2), 107–111. (In Ukrainian) doi: 10.15407/biotech8.02.107

      10. Matyshevska O. P., Prylutska S. V., Grynyuk I. I. Fullerenes C60 as bioactive molecules. I. Physical and chemical properties and bioavailability. Biotekhnolohiia. 2010, V.3, N 1, P. 18–26. (In Ukrainian)

      11. Piotrovskyy L. B., Kiselyov O. I. Fullerenes in biology (on the way to nanomedicine). St. Petersbourg: Rostoc. 2006, 336. (In Russian)

      12. Sun T., Xu Z. Radical scavenging activities of alpha-alanine C60 adduct. Bioorg. Med.Chem. Lett. 2006, V.16, P. 3731–3734. http://dx.doi.org/10.1016/j.bmcl.2006.04.052

      13. Prylutska S. V., Grynyuk I. I., Matyshevska O. P., Prylutskyy Yu. I., Ritter U., Scharff P. Anti-oxidant properties of C60 fullerenes n vitro. Fullerenes, Nanotubes, Carbon Nanostruct. 2008, V. 16, P. 698–705. http://dx.doi.org/10.1080/15363830802317148

      14. Rouse J. G., Yang J., Barton A. R., Monteiro-Reviere N. A. Fullerene_based amino acid nanoparticle interactions with human epidermal keratinocytes. Toxicol. in vitro. 2006, V. 20, P. 1313–1320. http://dx.doi.org/10.1016/j.tiv.2006.04.004

      15. Sayes C. M., Fortner J. D., Guo W., Lyon D., Boyd A. M., Ausman K. D., Tao Y. J., Sitharaman B., Wilson L. J., Hughes J. B., West J. L., Colvin V. L. The differential cytotoxicity of water_soluble fullerenes. Nano Lett. 2004, V. 4, P. 1881–1887. http://dx.doi.org/10.1021/nl0489586

      16. Kolosnjaj J., Szwarc H., Moussa F. Toxicity studies of fullerenes and derivatives. Adv. Exp. Med. Biol. 2007, N 620, P. 168–180. http://dx.doi.org/10.1007/978-0-387-76713-0_13

      17. Prylutska S. V., Matyshevska O. P., Golub A. А., Prylutskyy Yu. I., Potebnya G. P., Ritter U., Scharff P. Study of С60 fullerenes and С60-containing composites cytotoxicity in vitro. Mater. Sci. Engineer. C. 2007, V. 27, P. 1121–1124.

      18. Prylutska S. V., Grynyuk I. I., Grebinyk S. M., Matyshevska O. P., Prylutskyy Yu. I., Ritter U., Siegmund C., Scharff P. Comparative study of biological action of fullerenes C60 and carbon nanotubes in thymus cells. Mat.-wiss. u. Werkstofftech., 2009, 40(4), 238–241.
      http://dx.doi.org/10.1002/mawe.200900433

      19. Zavarzin A.A. Comparative histology. St. Petersbourg: St. Petersbourg University Press. 2000, 520. (In Russian).

      20. http://rupest.ru

      21. Oliynychenko P. I., Bulkina Z. P., Siniborova T. I. Handbook of tumor polichemo therapy. Kyiv: Zdorovja. 2000, 301. (In Russian)

      22. Kuznietsova H. M., Ogloblya O. V., Rybalchenko V. K. Impact of dihyd ropyrrol derivative in the normal colonic mucosa of DMH-induced colon cancer rats compared with 5-fluorouracil. Exper. Oncol. 2013, 5(1), 25–29.

      23. OECD Guidelines for the Testing of Chemicals/Section 2: Effects on Biotic Systems Test No. 213: Honeybees, Acute Oral Toxicity Test. OECD Publishing. 2011, V. 12.

      24. Prylutskyy Yu. I., Petrenko V. I., Ivankov O. I., Kyzyma O. A., Bulavin L. A., Litsis O. O., Evstigneev M. P., Cherepanov V. V., Naumovets A. G., Ritter U. On the origin of C60 fullerene solubility in aqueous solution. Langmuir. 2014, 30(14), 3967–3970.
      http://dx.doi.org/10.1021/la404976k

      25. Ritter U., Prylutskyy Yu. I.,Evstigneev M. P., Davidenko N. A., Cherepanov V. V., Senenko A. I., Marchenko O. A., Naumovets A. G. Structural features of highly stable reproducible C60 fullerene aqueous colloid solution probed by various techniques. Fullerenes, Nanotubes, Carbon Nanostruct. 2015, 23(6), 530–534. http://dx.doi.org/10.1080/1536383X.2013.870900

      26. Prylutskyy Yu. I., Buchelnikov A. S., Voronin D. P., Kostjukov V. V., Ritter U., Parkinson J. A., Evstigneev M. P. C60 fullerene aggregation in aqueous solution. Phys. Chem. Chem. Phys. 2013, 15(23), 9351–9360. http://dx.doi.org/10.1039/c3cp50187f

      27. Eskov E. K., Eskova M. D., Spasik S. E. Changes in Body Mass and Life Span of Honeybee Apis mellifera L. under Effect of Narcotization with Carbon Dioxide. J. Evol. Biochem. Physiol.2013, 49(6), 627–662. http://dx.doi.org/10.1134/S002209301306011X

      28. Prylutska S. V., Kichmarenko Yu. M., Bogutska K. I., Prylutskyy Yu. I. C60 fullerene and its derivates as anticancer agents: problems and perspectives. Biotekhnolohiia. 2012, 5(3), 9–17. (In Ukrainian).

      29. Gharbi N., Pressac M., Hadchouel M., Szwarc H., Wilson S.R., Moussa F. C60 fullerene is a powerful antioxidant in vivo with no acute or subacute toxicity. Nano Lett. 2005, V. 5, P. 2578.
      http://dx.doi.org/10.1021/nl051866b

      30. Poquet Y., Bodin L., Tchamitchian M., Fusellier M., Giroud B., Lafay F., Buleté A., Tchamitchian S., Cousin M., Pélissier M., Brunet J-L., Belzunces L.P. A pragmatic approach to assess the exposure of the honey bee (Apis mellifera) when subjected to pesticide spray. PLOS One. 2014, 9(11), e113728. http://dx.doi.org/10.1371/journal.pone.0113728

      31. Hall M. D., Okabe M., Shen D. W., Liang X. J., Gottesman M. M. The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy. Ann. Rev. Pharmacol. Toxicol. 2008, V.48, P. 495–535. http://dx.doi.org/10.1146/annurev.pharmtox.48.080907.180426

      32. Skvortsov A. N. The mechanism of cisplatin input into the cells through copper transport system. Autoref. of thesis of Dr. Sci. St. Petersbourg. 2011. (In Russian).

      33. Prylutska S. V., Didenko G. V., Kichmarenko Yu. M., Kruts O. О., Potebnya G. P., Cherepanov V. V., Prylutskyy Yu. I. Effect of the C60 fullerene, doxorubicin and their complex on cancer and normal cells of BALB/C mice. Biotechnol. acta. 2014,2014, 7(1), 60–65.
      doi: 10.15407/biotech7.01.060


 

Additional menu

Site search

Site navigation

Home Archive 2015 № 4 EFFECTS OF C60 FULLERENE — CISPLATIN COMPLEX ON HONEYBEE Apis mellifera L. Kuznietsova H. M., Ogloblya O. V., Cherepanov V. V., Prylutskyy Yu. I., Rybalchenko V. K.

Invitation to cooperation

Dear colleagues, we invite you to publish your articles in our journal.
© Palladin Institute of Biochemistry of the National Academy of Sciences of Ukraine, 2008.
All rights are reserved. Complete or partial reprint of the journal is possible only with the written permission of the publisher.
E-mail
for information: biotech@biochem.kiev.ua.